The program’s goal is to pioneer a new limb replacement technique without using anti-rejection drugs that could threaten a patient’s life. The surgeons instead transplant donor bone marrow along with the patient’s hand so the immune system will accept the donated hand.
The surgeons will also use sensitive immune monitoring techniques to minimize the drugs patients need during the procedure.
Sign up for our FREE Orthopedic E-Weekly for more coverage like this sent to your inbox!
Related Articles on Orthopedic Surgery:
AAOS Releases Adolescent Elbow Fracture Care Guideline
Hip Surgeons Debate Efficacy of Hip Impingement Surgery
Red Sox Shake Up Medical Provider Model
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
